Conflicts of interest in the development of new interventional medical devices

MO Baerlocher, SF Millward, JF Cardella - Journal of vascular and …, 2009 - Elsevier
Conclusion There is substantial evidence demonstrating the effect of physician–industry
collaboration (and monetary rewards) on publication results in other fields. Conversely …

[HTML][HTML] A Response from Dr. Nancy Olivieri

N Olivieri - CMAJ, 2006 - Can Med Assoc
I write to correct the errors and misrepresentations in the review by Hoey and Todkill1 (“The
Olivieri story, take three”; Oct. 11, 2005) of Miriam Shuchman's book. 2 Many physicians may …

Doubts about lutein

A Giligson - CMAJ, 2006 - Can Med Assoc
5. FDA approves Novartis iron-removal drug. PharmacyOneSource. com. 2 Nov 2005 6.
Thompson J, Baird P, Downie J. The Olivieri Report: the complete text of the report of the …

Conflits d'intérêts (deuxième partie): acteurs et processus

JP Boissel - Médecine, 2007 - jle.com
Le processus au cours duquel risque de se manifester un conflit d'intérêts produit un
message ou une décision destinés à influencer une «cible». Les sources potentielles de …

[PDF][PDF] What about hunter–gatherers?

J Fisher - CMAJ, 2006 - Can Med Assoc
5. FDA approves Novartis iron-removal drug. PharmacyOneSource. com. 2 Nov 2005 6.
Thompson J, Baird P, Downie J. The Olivieri Report: the complete text of the report of the …

Doubts about lutein

S Santosa, PTH Jones - CMAJ, 2006 - Can Med Assoc
5. FDA approves Novartis iron-removal drug. PharmacyOneSource. com. 2 Nov 2005 6.
Thompson J, Baird P, Downie J. The Olivieri Report: the complete text of the report of the …